ILARIS
ILARIS
Approved
DIN Number
02460351
Drug Class
Human
Market Date
Aug 22, 2017
Company
HC
novartis pharmaceuticals canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02460351
AIG Number0152696001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L04AC08 CANAKINUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:28.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
CANAKINUMABActive
Strength: 150 MG / ML
Monograph: CANAKINUMAB